Machine learning prediction of anemia events before and after talazoparib dose modification using TALAPRO-2 phase 3 trial data

19/11/2024
21/08/2025
EU PAS number:
EUPAS1000000344
Study
Ongoing
Documents
Study protocol
Initial protocol
English (639.72 KB - PDF) View document
Updated protocol
English (267.14 KB - PDF) View document
Study results
Study report
Other information